CRIS Current Research Information System

CHIARINI, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.054
EU - Europa 1.853
AS - Asia 1.377
AF - Africa 129
SA - Sud America 91
OC - Oceania 3
Totale 5.507
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.032
IT - Italia 576
SG - Singapore 432
GB - Regno Unito 370
CN - Cina 358
VN - Vietnam 292
SE - Svezia 232
DE - Germania 213
HK - Hong Kong 140
IN - India 75
RU - Federazione Russa 74
BR - Brasile 68
UA - Ucraina 65
IE - Irlanda 60
NL - Olanda 54
FR - Francia 46
TG - Togo 41
EE - Estonia 35
FI - Finlandia 35
CI - Costa d'Avorio 30
ZA - Sudafrica 30
CH - Svizzera 22
BG - Bulgaria 19
JO - Giordania 17
SC - Seychelles 16
BE - Belgio 15
KR - Corea 14
CA - Canada 13
JP - Giappone 12
AR - Argentina 11
ID - Indonesia 10
HR - Croazia 9
NG - Nigeria 9
BD - Bangladesh 6
LT - Lituania 5
MX - Messico 5
EC - Ecuador 4
GR - Grecia 4
PL - Polonia 4
TR - Turchia 4
CZ - Repubblica Ceca 3
ES - Italia 3
PK - Pakistan 3
UZ - Uzbekistan 3
CO - Colombia 2
DK - Danimarca 2
IQ - Iraq 2
KZ - Kazakistan 2
NZ - Nuova Zelanda 2
PY - Paraguay 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AT - Austria 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
CL - Cile 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GI - Gibilterra 1
HN - Honduras 1
KE - Kenya 1
KG - Kirghizistan 1
LB - Libano 1
MD - Moldavia 1
MY - Malesia 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
SA - Arabia Saudita 1
SD - Sudan 1
SI - Slovenia 1
TW - Taiwan 1
Totale 5.507
Salva come PNG Salva come JPEG
Città #
Southend 316
Singapore 265
Ashburn 238
Parma 217
Fairfield 204
Chandler 182
Santa Clara 146
Hong Kong 140
Dong Ket 111
Ann Arbor 97
Wilmington 97
Woodbridge 96
Houston 93
Seattle 87
Bologna 80
Princeton 79
Cambridge 73
Beijing 64
Dublin 60
Boardman 55
Ho Chi Minh City 52
Lomé 41
Hanoi 38
Nanjing 33
Jacksonville 31
Reggio Emilia 31
Westminster 31
Abidjan 30
Helsinki 30
Padova 30
Hefei 26
Los Angeles 23
Bremen 22
Dallas 21
Redondo Beach 21
Berlin 20
Sofia 19
Saint Petersburg 18
Turin 18
Amman 17
Bern 16
Jinan 16
Falkenstein 15
Shenyang 15
Brussels 14
Des Moines 14
Seoul 14
Shanghai 14
Milan 12
Nanchang 12
São Paulo 12
Florence 11
Frankfurt am Main 11
Guangzhou 11
New York 11
San Diego 11
Changsha 10
Tianjin 10
Abeokuta 9
Medford 9
Washington 9
Hebei 8
Tokyo 8
Toronto 8
Haiphong 7
Hangzhou 7
Redmond 7
Rome 7
Buffalo 6
Falls Church 6
London 6
Moscow 6
Mülheim 6
Ningbo 6
Olalla 6
Phoenix 6
Redwood City 6
Haikou 5
Jakarta 5
Lappeenranta 5
Mahé 5
Mountain View 5
Norwalk 5
San Francisco 5
Udine 5
Amsterdam 4
Biên Hòa 4
Can Tho 4
Durham 4
Fuzhou 4
Istanbul 4
Jiaxing 4
Jundiaí 4
Ninh Bình 4
Verona 4
Warsaw 4
Brasília 3
Bühl 3
Da Nang 3
Elk Grove Village 3
Totale 3.710
Salva come PNG Salva come JPEG
Nome #
Antigene MYCN Silencing by BGA002 Inhibits SCLC Progression Blocking mTOR Pathway and Overcomes Multidrug Resistance 549
Lamin A and prelamin A counteract invasiveness of osteosarcoma cells 236
Activity of the novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235, against T-cell acute lymphoblastic leukemia. 201
AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications. 169
PI3K pan-inhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitors. 164
Toxicity of antimony trioxide nanoparticles on human hematopoietic progenitor cells and comparison to cell lines. 162
Alteration of Akt activity increases chemotherapeutic drug and hormonal resistance in breast cancer yet confers an achilles heel by sensitization to targeted therapy 159
Effect of Lenalidomide Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients 153
A role of PI-PLCb1 in G1/S transition in human erythroleukemia k562 cells 148
Involvement of nuclear PLC{beta}1 in lamin B1 phosphorylation and G2/M cell cycle progression. 147
Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor (2S)-1-(1H-Indol-3-yl)-3-[5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl]oxypropan2-ami ne (A443654) in T-cell acute lymphoblastic leukemia. 146
ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS, UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS 146
The Emerging Role of the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Signaling Network in Cancer Stem Cell Biology. 142
Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK- and PP2A-dependent mechanisms. 142
The cyclin-dependent kinase inhibitor roscovitine and the nucleoside analog sangivamycin induce apoptosis in caspase-3 deficient breast cancer cells independent of caspase mediated P-glycoprotein cleavage 138
The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation 138
Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor perifosine in acute myelogenous leukemia cells 138
Synergistic induction of PI-PLCbeta1 signaling by azacitidine and valproic acid in high-risk myelodysplastic syndromes 137
Lamin A acts a tumor suppressor in Ewing sarcoma promoting neural differentiation and reducing cell migration and invasion 137
Assessment of the structural and functional characteristics of human mesenchymal stem cells associated with a prolonged exposure of morphine 135
The phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin signaling network and the control of normal myelopoiesis 131
Synergistic proapoptotic activity of recombinant TRAIL plus the Akt inhibitor perifosine in acute myeloid leukemia cells. 129
The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resisten human T-acute leukemia cells by a JNK-dependent mechanism 128
Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS. 126
Targeted inhibition of mTORC1 and mTORC2 by active-site mTOR inhibitors has cytotoxic effects in T-cell acute lymphoblastic leukemia. 123
Inhibition of methyltransferase dot1l sensitizes to sorafenib treatment aml cells irrespective of mll-rearrangements: A novel therapeutic strategy for pediatric aml 121
Dual inhibition of class IA phoshatidylinositol 3-kinase and mTOR as a new therapeutic option for T-cell acute lymphoblastic leukemia. 120
Effect of Erythropoietin Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients. 118
Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin module for acute myelogenous leukemia therapy: from bench to bedside. 111
The emerging role of the phosphatidylinositol 3-kinase/Akt/mTOR signaling network in normal myelopoieis and leukemogenesis. 105
Temsirolimus, an mTOR inhibitor, in combination with lower-dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: results of a phase II GIMEMA study (AML-1107). 103
A COMBINATION OF BORTEZOMIB WITH CX-4945, A CASEIN KINASE 2 (CK2) INHIBITOR, HAS SYNERGISTIC CYTOTOXIC EFFECTS IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CELL LINES 101
Cellular senescence in vascular wall mesenchymal stromal cells, a possible contribution to the development of aortic aneurysm 99
Temsirolimus, An Allosteric mTORC1 Inhibitor, Is Synergistic with Clofarabine in AML and AML Leukemia Initiating Cells 96
The role played by Wnt/beta-catenin signaling pathway in acute lymphoblastic leukemia. 90
Targeting metabolic vulnerabilities and aberrant signal transduction pathways in paediatric T-cell Acute Lymphoblastic Leukaemia (T-ALL) 82
The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients 77
The unfolded protein response: a novel therapeutic target in acute leukemias. 75
null 69
Targeting the phosphatidylinositol 3-kinase/Akt/mTOR signaling network in acute myelogenous leukaemia. 65
Preclinical testing of the Akt inhibitor triciribine in T-cell acute lymphoblastic leukemia 62
Totale 5.618
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.003
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.003
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021284 0 0 0 0 0 12 6 33 39 22 21 151
2021/2022797 87 24 54 54 68 32 15 64 25 128 140 106
2022/2023885 79 110 45 113 67 70 32 45 152 34 87 51
2023/2024343 19 39 32 38 23 59 13 13 10 38 21 38
2024/20251.047 31 113 134 82 214 71 75 42 9 52 44 180
2025/2026925 145 210 161 115 234 60 0 0 0 0 0 0
Totale 5.618